Her-2/neu and EGFR tyrosine kinase activation predict the efficacy of trastuzumab-based therapy in patients with metastatic breast cancer
Gernot Hudelist, Wolfgang J. Köstler, Klaus Czerwenka, Ernst Kubista, Johannes Attems, Ruth Müller, Daphne Gschwantler-Kaulich, Mahmood Manavi, Isabell Huber, Heinz Hoschützky, Christoph C. Zielinski,Volume:
118
Year:
2006
Language:
english
Pages:
9
DOI:
10.1002/ijc.21492
File:
PDF, 372 KB
english, 2006